Published in Eur Arch Psychiatry Clin Neurosci on July 20, 2013
Neuroimaging-based biomarkers for treatment selection in major depressive disorder. Dialogues Clin Neurosci (2014) 0.91
Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder. Mol Psychiatry (2014) 0.83
Prefrontal thinning affects functional connectivity and regional homogeneity of the anterior cingulate cortex in depression. Neuropsychopharmacology (2015) 0.78
Resting-state functional connectivity of antero-medial prefrontal cortex sub-regions in major depression and relationship to emotional intelligence. Int J Neuropsychopharmacol (2015) 0.76
Demonstrating test-retest reliability of electrophysiological measures for healthy adults in a multisite study of biomarkers of antidepressant treatment response. Psychophysiology (2017) 0.75
Predicting cognitive behavioral therapy response in social anxiety disorder with anterior cingulate cortex and amygdala during emotion regulation. Neuroimage Clin (2017) 0.75
Reward, memory and prediction of treatment response in affective disorders. Eur Arch Psychiatry Clin Neurosci (2014) 0.75
Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp (2002) 25.56
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry (2006) 14.15
Deep brain stimulation for treatment-resistant depression. Neuron (2005) 12.39
Wandering minds: the default network and stimulus-independent thought. Science (2007) 12.30
Placebo response in studies of major depression: variable, substantial, and growing. JAMA (2002) 7.56
Standardized low-resolution brain electromagnetic tomography (sLORETA): technical details. Methods Find Exp Clin Pharmacol (2002) 7.49
A meta-analytic study of changes in brain activation in depression. Hum Brain Mapp (2008) 3.19
Focused attention, open monitoring and automatic self-transcending: Categories to organize meditations from Vedic, Buddhist and Chinese traditions. Conscious Cogn (2010) 3.12
Default-mode and task-positive network activity in major depressive disorder: implications for adaptive and maladaptive rumination. Biol Psychiatry (2011) 3.09
Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology (2010) 2.97
How is our self related to midline regions and the default-mode network? Neuroimage (2011) 2.41
Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry (1999) 2.32
Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am J Psychiatry (2001) 2.31
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry (2006) 2.29
The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry (2003) 2.19
Individual differences in trait rumination and the neural systems supporting cognitive reappraisal. Cogn Affect Behav Neurosci (2005) 2.03
Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings. Biol Psychiatry (2007) 1.90
Evidence of a dissociation pattern in resting-state default mode network connectivity in first-episode, treatment-naive major depression patients. Biol Psychiatry (2011) 1.87
Depression, rumination and the default network. Soc Cogn Affect Neurosci (2010) 1.86
Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine. Neuropsychopharmacology (2010) 1.65
Frontal theta EEG activity correlates negatively with the default mode network in resting state. Int J Psychophysiol (2007) 1.56
Impact of meditation training on the default mode network during a restful state. Soc Cogn Affect Neurosci (2012) 1.54
The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants. J Psychopharmacol (2010) 1.51
Neural correlates of rumination in depression. Cogn Affect Behav Neurosci (2010) 1.49
Medial cortex activity, self-reflection and depression. Soc Cogn Affect Neurosci (2009) 1.48
Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. J Clin Psychiatry (2009) 1.42
Tracking the train of thought from the laboratory into everyday life: an experience-sampling study of mind wandering across controlled and ecological contexts. Psychon Bull Rev (2009) 1.39
Resting-state brain activity in schizophrenia and major depression: a quantitative meta-analysis. Schizophr Bull (2011) 1.26
Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures. CNS Spectr (2008) 1.25
Changes in brain metabolism associated with remission in unipolar major depression. Acta Psychiatr Scand (2004) 1.18
Rumination-focused cognitive-behavioural therapy for residual depression: phase II randomised controlled trial. Br J Psychiatry (2011) 1.18
Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. J Psychiatry Neurosci (2009) 1.16
Biomarkers to predict antidepressant response. Curr Psychiatry Rep (2010) 1.14
Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression. J Affect Disord (2008) 1.13
The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology (Berl) (2000) 1.13
Frontal EEG predictors of treatment outcome in major depressive disorder. Eur Neuropsychopharmacol (2009) 1.08
Effects of sleep deprivation on the limbic system and the frontal lobes in affective disorders: a study with Tc-99m-HMPAO SPECT. Psychiatry Res (1991) 1.06
Prediction of treatment response in major depression: integration of concepts. J Affect Disord (2006) 1.04
Improved anatomic delineation of the antidepressant response to partial sleep deprivation in medial frontal cortex using perfusion-weighted functional MRI. Psychiatry Res (2006) 1.03
The efficacy of mindfulness-based cognitive therapy in recurrent depressed patients with and without a current depressive episode: a randomized controlled trial. Psychol Med (2011) 1.02
Brooding and pondering: isolating the active ingredients of depressive rumination with exploratory factor analysis and structural equation modeling. Assessment (2009) 1.00
Why ruminators won't stop: the structural and resting state correlates of rumination and its relation to depression. J Affect Disord (2012) 0.96
Slow EEG pattern predicts reduced intrinsic functional connectivity in the default mode network: an inter-subject analysis. Neuroimage (2010) 0.96
Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta -50T/C single nucleotide polymorphism. Biol Psychiatry (2007) 0.94
Description and measurement of concentration problems in depressed patients. Psychol Med (1985) 0.91
Predictive socioeconomic and clinical profiles of antidepressant response and remission. Depress Anxiety (2013) 0.90
Rostral anterior cingulate cortex activity in the theta band predicts response to antidepressive medication. Clin EEG Neurosci (2007) 0.89
Brain electrical source differences between depressed subjects and healthy controls. Brain Topogr (2008) 0.89
Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression. Clin Neurophysiol (2009) 0.89
Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy. J Affect Disord (2008) 0.89
Efficacy of an algorithm-guided treatment compared with treatment as usual: a randomized, controlled study of inpatients with depression. J Clin Psychopharmacol (2009) 0.88
Meditators and non-meditators: EEG source imaging during resting. Brain Topogr (2009) 0.87
The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder. Psychiatr Clin North Am (2007) 0.86
Electrophysiological correlates of anxious rumination. Int J Psychophysiol (2008) 0.85
Functional connectivity of brain structures correlates with treatment outcome in major depressive disorder. Front Psychiatry (2011) 0.85
Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved. Front Pharmacol (2013) 0.84
The implication of functional connectivity strength in predicting treatment response of major depressive disorder: a resting EEG study. Psychiatry Res (2011) 0.84
Changes in regional cerebral blood flow following mood challenge in drug-free, remitted patients with unipolar depression. Depress Anxiety (2007) 0.83
Medial prefrontal cortex activity during memory encoding of pictures and its relation to symptomatic improvement after citalopram treatment in patients with major depression. J Psychiatry Neurosci (2010) 0.82
EEG topography and tomography (LORETA) in the classification and evaluation of the pharmacodynamics of psychotropic drugs. Clin EEG Neurosci (2006) 0.81
Genetic variations of the NR3A subunit of the NMDA receptor modulate prefrontal cerebral activity in humans. J Cogn Neurosci (2007) 0.81
Response styles to depressed mood affect the long-term course of psychosocial functioning in depressed patients. J Affect Disord (2011) 0.80
Serotonin transporter gene and response to lithium augmentation in depression. Psychiatr Genet (2008) 0.79
Baseline thyroid indices and the subsequent response to citalopram treatment, a pilot study. Brain Behav (2013) 0.75
Chronic and treatment resistant depression: diagnosis and stepwise therapy. Dtsch Arztebl Int (2014) 3.14
Treatment of depressive disorders. Dtsch Arztebl Int (2008) 2.96
Take home maintenance medication in opiate dependence. Dtsch Arztebl Int (2013) 2.46
Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics. Psychopharmacology (Berl) (2006) 2.23
Adolescent impulsivity phenotypes characterized by distinct brain networks. Nat Neurosci (2012) 1.98
Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) (2005) 1.77
Lower ventral striatal activation during reward anticipation in adolescent smokers. Am J Psychiatry (2011) 1.70
Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla. Neuroimage (2004) 1.68
Common biology of craving across legal and illegal drugs - a quantitative meta-analysis of cue-reactivity brain response. Eur J Neurosci (2011) 1.62
Response and remission criteria in major depression--a validation of current practice. J Psychiatr Res (2010) 1.52
Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine. Psychopharmacology (Berl) (2007) 1.49
Reward feedback alterations in unmedicated schizophrenia patients: relevance for delusions. Biol Psychiatry (2009) 1.48
BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology (2004) 1.44
Association of BDNF serum concentrations with central serotonergic activity: evidence from auditory signal processing. Neuropsychopharmacology (2005) 1.44
Kinematic analysis of the effects of donepezil hydrochloride on hand motor function in patients with Alzheimer dementia. J Clin Psychopharmacol (2003) 1.43
Predictive value of isolated epileptiform discharges for a favorable therapeutic response to antiepileptic drugs in nonepileptic psychiatric patients. J Clin Neurophysiol (2014) 1.39
Resting-state brain activity in schizophrenia and major depression: a quantitative meta-analysis. Schizophr Bull (2011) 1.26
Reduced thickness of medial orbitofrontal cortex in smokers. Biol Psychiatry (2010) 1.21
Hyporeactivity of ventral striatum towards incentive stimuli in unmedicated depressed patients normalizes after treatment with escitalopram. J Psychopharmacol (2011) 1.17
Examining the gateway to the limbic system with diffusion tensor imaging: the perforant pathway in dementia. Neuroimage (2005) 1.16
Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls. Psychiatry Res (2009) 1.15
The neural correlates of subjective pleasantness. Neuroimage (2012) 1.15
Gray matter correlates of posttraumatic stress disorder: a quantitative meta-analysis. Biol Psychiatry (2012) 1.14
Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression. J Affect Disord (2008) 1.13
Catechol-O-methyltransferase val158met genotype influences neural processing of reward anticipation. Neuroimage (2008) 1.12
Test-retest reliability of P50, N100 and P200 auditory sensory gating in healthy subjects. Int J Psychophysiol (2007) 1.11
Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.11
Altered representation of expected value in the orbitofrontal cortex in mania. Hum Brain Mapp (2010) 1.10
Quantitative meta-analysis on state and trait aspects of auditory verbal hallucinations in schizophrenia. Schizophr Bull (2010) 1.10
Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking. Psychopharmacology (Berl) (2006) 1.09
Different aspects of theory of mind in paranoid schizophrenia: evidence from a video-based assessment. Psychiatry Res (2010) 1.07
Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project. J Clin Psychiatry (2010) 1.07
An integrated genome research network for studying the genetics of alcohol addiction. Addict Biol (2010) 1.07
Range of sensory gating values and test-retest reliability in normal subjects. Psychophysiology (2007) 1.06
Association between oxytocin receptor gene polymorphisms and self-rated 'empathic concern' in schizophrenia. PLoS One (2012) 1.06
RASGRF2 regulates alcohol-induced reinforcement by influencing mesolimbic dopamine neuron activity and dopamine release. Proc Natl Acad Sci U S A (2012) 1.06
Role of lithium augmentation in the management of major depressive disorder. CNS Drugs (2014) 1.06
Brains online: structural and functional correlates of habitual Internet use. Addict Biol (2014) 1.05
Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance. Am J Med Genet B Neuropsychiatr Genet (2010) 1.05
Determinants of early alcohol use in healthy adolescents: the differential contribution of neuroimaging and psychological factors. Neuropsychopharmacology (2011) 1.03
A quantitative meta-analysis on cue-induced male sexual arousal. J Sex Med (2011) 1.02
Brain grey matter deficits in smokers: focus on the cerebellum. Brain Struct Funct (2011) 1.01
The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia. Neurotox Res (2006) 1.00
Acute exercise ameliorates reduced brain-derived neurotrophic factor in patients with panic disorder. Psychoneuroendocrinology (2009) 1.00
Venous drainage patterns in a case of pseudotumor cerebri following unilateral radical neck dissection. Acta Otolaryngol (2003) 0.98
The International Consortium on Lithium Genetics (ConLiGen): an initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment. Neuropsychobiology (2010) 0.98
Lithium augmentation therapy in refractory depression-update 2002. Eur Arch Psychiatry Clin Neurosci (2003) 0.98
Serotonergic dysfunction in schizophrenia assessed by the loudness dependence measure of primary auditory cortex evoked activity. Schizophr Res (2003) 0.98
"Keep calm and carry on": structural correlates of expressive suppression of emotions. PLoS One (2011) 0.98
Variations in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) are associated with bipolar i disorder. Neuropsychopharmacology (2006) 0.97
Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia. Schizophr Res (2008) 0.97
Interaction of hippocampal volume and N-acetylaspartate concentration deficits in schizophrenia: a combined MRI and 1H-MRS study. Neuroimage (2010) 0.97
Association of attentional network function with exon 5 variations of the CHRNA4 gene. Hum Mol Genet (2007) 0.97
Whodunnit? Electrophysiological correlates of agency judgements. PLoS One (2011) 0.97
Cortical thickness correlates with impulsiveness in healthy adults. Neuroimage (2011) 0.96
Why ruminators won't stop: the structural and resting state correlates of rumination and its relation to depression. J Affect Disord (2012) 0.96
Long-term effectiveness of lithium in bipolar disorder: a multicenter investigation of patients with typical and atypical features. J Clin Psychiatry (2008) 0.95
Cortical hypoactivation during resting EEG in schizophrenics but not in depressives and schizotypal subjects as revealed by low resolution electromagnetic tomography (LORETA). Psychiatry Res (2002) 0.95
Structural correlates of trait anxiety: reduced thickness in medial orbitofrontal cortex accompanied by volume increase in nucleus accumbens. J Affect Disord (2011) 0.95
Theory of mind impairments in euthymic bipolar patients. J Affect Disord (2009) 0.95
New evidence for involvement of the entorhinal region in schizophrenia: a combined MRI volumetric and DTI study. Neuroimage (2004) 0.95
Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating. Proc Natl Acad Sci U S A (2012) 0.94
Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta -50T/C single nucleotide polymorphism. Biol Psychiatry (2007) 0.94
Creating probabilistic maps of the face network in the adolescent brain: a multicentre functional MRI study. Hum Brain Mapp (2011) 0.94
Subtle deficits of cognitive theory of mind in unaffected first-degree relatives of schizophrenia patients. Eur Arch Psychiatry Clin Neurosci (2011) 0.94
Polymorphisms in the N-methyl-D-aspartate receptor 1 and 2B subunits are associated with alcoholism-related traits. Biol Psychiatry (2003) 0.94
Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factors. Eur Arch Psychiatry Clin Neurosci (2014) 0.93
Outcomes of 1014 naturalistically treated inpatients with major depressive episode. Eur Neuropsychopharmacol (2010) 0.93
Attentional modulation of emotional stimulus processing in patients with major depression--alterations in prefrontal cortical regions. Neurosci Lett (2009) 0.92
A preliminary study of increased amygdala activation to positive affective stimuli in mania. Bipolar Disord (2009) 0.91
Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers. Eur Neuropsychopharmacol (2008) 0.91
Serotonergic dysfunction in the prodromal, first-episode and chronic course of schizophrenia as assessed by the loudness dependence of auditory evoked activity. Schizophr Res (2009) 0.91
Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation. Schizophr Res (2010) 0.91
Pharmacogenetic insights to monoaminergic dysfunction in alcohol dependence. Psychopharmacology (Berl) (2004) 0.90
Persistent dysfunctional frontal lobe activation in former smokers. Psychopharmacology (Berl) (2006) 0.90
Reduction of auditory event-related P300 amplitude in subjects with at-risk mental state for schizophrenia. Schizophr Res (2008) 0.90
Oxytocin and oxytocin receptor gene polymorphisms and risk for schizophrenia: a case-control study. World J Biol Psychiatry (2012) 0.89
Clinical predictors of response and remission in inpatients with depressive syndromes. J Affect Disord (2011) 0.89
Switching schizophrenia patients from typical neuroleptics to olanzapine: effects on BOLD response during attention and working memory. Eur Neuropsychopharmacol (2008) 0.89
Prefrontal cortex glutamate correlates with mental perspective-taking. PLoS One (2008) 0.89
Automatic approach bias towards smoking cues is present in smokers but not in ex-smokers. Psychopharmacology (Berl) (2013) 0.88
Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report. PLoS One (2013) 0.88
Efficacy of an algorithm-guided treatment compared with treatment as usual: a randomized, controlled study of inpatients with depression. J Clin Psychopharmacol (2009) 0.88
P300 subcomponents in obsessive-compulsive disorder. J Psychiatr Res (2002) 0.87
Impaired sleep quality and sleep duration in smokers-results from the German Multicenter Study on Nicotine Dependence. Addict Biol (2012) 0.87
Neurocognitive impairments in non-deprived smokers--results from a population-based multi-center study on smoking-related behavior. Addict Biol (2012) 0.87
Long-term lithium treatment and thyroid antibodies: a controlled study. J Psychiatry Neurosci (2005) 0.87
Reduction of cerebellar grey matter in Crus I and II in schizophrenia. Brain Struct Funct (2011) 0.86
Association of the dopamine D2 receptor gene with alcohol dependence: haplotypes and subgroups of alcoholics as key factors for understanding receptor function. Pharmacogenet Genomics (2009) 0.86
Increased neural activity during high working memory load predicts low relapse risk in alcohol dependence. Addict Biol (2013) 0.86
Lithium's emerging role in the treatment of refractory major depressive episodes: augmentation of antidepressants. Neuropsychobiology (2010) 0.86
Evaluation of time memory in acutely depressed patients, manic patients, and healthy controls using a time reproduction task. Eur Psychiatry (2008) 0.86
Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects. Eur Arch Psychiatry Clin Neurosci (2009) 0.85
Nerve growth factor serum concentrations in healthy human volunteers: physiological variance and stability. Neurosci Lett (2003) 0.85
Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials. J Clin Psychiatry (2010) 0.85
A phenotypic structure and neural correlates of compulsive behaviors in adolescents. PLoS One (2013) 0.85
Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms. Can J Psychiatry (2003) 0.85
The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode. Int J Neuropsychopharmacol (2008) 0.85
Association between variation in the vesicular monoamine transporter 1 gene on chromosome 8p and anxiety-related personality traits. Neurosci Lett (2008) 0.85
The amygdala in schizophrenia: a trimodal magnetic resonance imaging study. Neurosci Lett (2004) 0.84